Industry Briefs

Death Rays Into Plowshares The Strategic Defense Initiative may never shoot down an intercontinental ballistic missile, but the laser technology it developed at the Lawrence Livermore National Laboratory in Livermore, Calif., is about to be put to work performing eye surgery. The San Francisco-based Phoenix Laser Systems Inc., founded by physicists Alfred Sklar, Allen Frank, and other members of Livermore's Theoretical Physics Group in 1987, has developed a low-energy neodymium YAG laser to per

| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

Death Rays Into Plowshares The Strategic Defense Initiative may never shoot down an intercontinental ballistic missile, but the laser technology it developed at the Lawrence Livermore National Laboratory in Livermore, Calif., is about to be put to work performing eye surgery. The San Francisco-based Phoenix Laser Systems Inc., founded by physicists Alfred Sklar, Allen Frank, and other members of Livermore's Theoretical Physics Group in 1987, has developed a low-energy neodymium YAG laser to perform corneal laser sculpting. They expect the procedure will be able to treat a number of vision disorders, including glaucoma, and eventually make it possible for near- and far-sighted people to see without eyeglasses. Last month the company, which had its initial public offering in August 1989, unveiled its first integrated ophthalmic surgical workstation. The workstation involves a highly accurate tracking and targeting system first developed to track missile and explosion ejecta. Phoenix says the laser, directed ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies